From multi-tenant SaaS to fully air-gapped sovereign installations — every deployment option includes dedicated FDEs, FDA 21 CFR Part 11 compliance, and full Evidence Engine access.
Start anywhere on the sovereignty spectrum. Migrate seamlessly as your requirements evolve.
Logically isolated multi-tenant deployment with automatic updates, zero infrastructure overhead, and automatic scaling. Ideal for early-stage biotechs, academic research labs, and teams evaluating AI governance platforms.
Best for: Early-stage biotechs, academic research, CROs
Fully isolated single-tenant environment managed by BioCompute. Bring your own encryption keys, set custom data retention policies, and maintain complete audit trail ownership. Best for mid-to-large pharma and established biotechs.
Best for: Mid-to-large pharma, established biotech, diagnostics
BioCompute deploys directly into your cloud account, inside your VPC, behind your firewall rules. Data never crosses your network boundary. Achieves FDA Part 11 closed-system classification. For enterprises with strict data residency requirements.
Best for: Large pharma, government-adjacent, EU data residency
Fully disconnected deployment on on-premise hardware. No internet connectivity, no external dependencies. FIPS 140-2 encryption. For classified research programs, defense biotech, and sovereign national science initiatives.
Best for: Defense biotech, classified research, sovereign programs
No matter how you deploy, you get the full BioCompute platform
Forward Deployed Engineers embed with your team to own deployment outcomes — from architecture design through production go-live and ongoing optimization.
FDA compliance is built into every layer. Automatic audit trails, electronic signatures, immutable evidence books.
Generate submission-ready evidence packages from day one. SOC 2, HIPAA, GDPR, FDA, EU AI Act compliant.
We handle infrastructure, updates, scaling, and security. You focus on science and discovery.
Everything you need to know about deploying BioCompute